The Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media to discuss trends in tobacco use, the implications of new graphic warning requirements for cigarette packages and ads, and concerns involving products like nicotine pouches and e-cigarettes.
Manufacturing tweaks to subcutaneous Tecentriq delay Roche’s US launch, CMC processes to be updated by year’s end
Roche informed its drug delivery tech partner Halozyme Therapeutics that the US launch of the subcutaneous version of Tecentriq will be delayed to next year